Sirtris Pharmaceuticals Inc is categorized under in Cambridge, MA and active since 2008.
Sirtris Pharmaceuticals Inc was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact Christoph Westphal, Chief Executive Officer at the company’s single location by writing to 200 Technology Square, Cambridge, Massachusetts MA 02139 or by phoning (617) 252-6920. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sirtris Pharmaceuticals Inc |
| Contact Person: | Christoph Westphal, Chief Executive Officer |
| Address: | 200 Technology Square, Cambridge, Massachusetts 02139 |
| Phone Number: | (617) 252-6920 |
| Website Address: | sirtrispharma.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | |
| SIC Code: | 2834 |
| NAICS Code: | 3254120 |
| Share This Business: |
Sirtris Pharmaceuticals Inc was started in 2008 to provide professional under the SIC code 2834 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Christoph Westphal, Chief Executive Officer for inquiries that concern Sirtris Pharmaceuticals Inc by calling the company number (617) 252-6920, as your correspondence is most welcome. Additionally, the physical location of the single location of Sirtris Pharmaceuticals Inc can be found at the coordinates 42.363521,-71.091253 as well as the street address 200 Technology Square in Cambridge, Massachusetts 02139.
For its online presence, you may visit Sirtris Pharmaceuticals Inc’s website at sirtrispharma.com and engage with its social media outlets through on Twitter and on Facebook.